Skip to content

Fluorescent antibody test for antibodies against flaviviruses (e.g., dengue, West Nile)

Published: August 9, 2026Updated: August 16, 2026

This test detects antibodies that your immune system produces in response to exposure to flaviviruses, such as dengue or West Nile virus. It helps identify whether you may have been infected recently or in the past.

Quick summary

["This test checks for past or recent exposure to flaviviruses that can cause serious illnesses."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
7922-8
Short code
FLUAV Eng Ab Ser-aCnc
Synonyms
FLUAV Eng Ab Ser-aCnc
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

The test looks for specific antibodies (immunoglobulins) in your blood that target flaviviruses. These antibodies develop after your body encounters the virus, either through infection or vaccination. The presence of these antibodies suggests exposure, though timing and levels can vary depending on when infection occurred.

Why It Matters for You

Identifying flavivirus exposure is important for diagnosing infections, especially in areas where these viruses are common. It can also help guide treatment decisions or inform public health measures. This test is often used alongside other diagnostic tools for confirmation.

How the Test Works

The test uses a fluorescent immunoassay (fia) method to detect antibodies in your serum. A sample of your blood is exposed to flavivirus antigens, and if antibodies are present, they bind and fluoresce under a microscope, indicating a positive result.

What to Expect Before the Test

No special preparation is needed for this test. You may have a small needle inserted into your arm to draw blood, which typically takes a few minutes. If you’re on blood-thinning medication, let your healthcare provider know before the test.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

Flavivirus antibody screening

Frequently asked questions

How long does it take to get results from this test?
Results are usually available within 1–3 business days, depending on lab processing times. Your healthcare provider will discuss the findings with you during your follow-up visit.
Can this test differentiate between different flaviviruses?
This test detects antibodies against a broad group of flaviviruses, but it may not distinguish between specific viruses like dengue or West Nile. Additional tests may be needed for precise identification.
What symptoms might indicate flavivirus infection?
Symptoms can include fever, headache, body aches, nausea, vomiting, or rash. Some infections, like dengue, can cause severe complications such as bleeding or organ failure, especially in untreated cases. If you develop these symptoms after travel to a high-risk area, consult a healthcare provider.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy